TCG Lifesciences Enters Into A Research Collaboration with ENDO Pharmaceuticals


TCG Lifesciences has announced a strategic collaboration with ENDO Pharmaceuticals to discover novel small molecule drug candidates for the treatment of pain. Working closely with ENDO scientists the collaboration will focus on an integrated approach involving medicinal chemistry, biology and animal pharmacology capabilities of Chembiotek. ENDO will have full ownership of the compounds developed under the collaboration with exclusive worldwide rights, and will fund all subsequent drug development and commercialization activities. ENDO will provide research funding and pay success based discovery milestones payments to TCG Lifesciences.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top